Unlocking the potential for microbiome‐based therapeutics to address the sustainable development goal of good health and wellbeing
Abstract Recent years have witnessed major advances and an ever‐growing list of healthcare applications for microbiome‐based therapeutics. However, these advances have disproportionately targeted diseases common in high‐income countries (HICs). Within low‐ to middle‐income countries (LMIC), opportun...
| Published in: | Microbial Biotechnology |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-11-01
|
| Online Access: | https://doi.org/10.1111/1751-7915.70041 |